Yusheng Yao 1,2 , Hao Li 2 , Qiaolan He 3 , Tingting Chen 4 , Yihang Wang 3 , Xiaochun Zheng 5,2 . Show Affiliations »
Abstract
Show RCT »
Hide RCT «
BACKGROUND: Erector spinae plane block (ESPB ) is a novel regional anesthesia technique that is gaining popularity for postoperative pain management. This randomized controlled trial evaluated the effect of ESPB on quality of recovery (QoR ) in patients undergoing modified radical mastectomy . METHODS: Eighty-two female patients undergoing modified radical mastectomy were included. Patients were randomly assigned to receive preoperative ultrasound-guided ESPB with either 0.5% ropivacaine or saline . The primary outcome was QoR, assessed 24 hours postoperatively using the 15-item QoR questionnaire (QoR-15 ). Secondary outcomes included postoperative pain scores, postoperative cumulative opioid consumption, postanesthesia care unit (PACU ) discharge time, postoperative nausea or vomiting and dizziness . RESULTS: Global QoR-15 scores 24 hours postoperatively were significantly higher (indicating better quality) in the ESPB group (median 120, IQR 118-124) compared with the control group (median 110, IQR 108.3-112.8), with a median difference of 10 (95% CI 9 to 12, p<0.001). Compared with the control group, ESPB with ropivacaine reduced pain scores up to 8 hours after surgery, as well as reduced postoperative cumulative opioid consumption and PACU discharge time . CONCLUSIONS: A single preoperative injection of ESPB with ropivacaine may improve QoR postoperatively and acute postoperative analgesia in patients undergoing a modified radical mastectomy . TRIAL REGISTRATION NUMBER: ChiCTR-1800019599. © American Society of Regional Anesthesia & Pain Medicine 2019. No commercial re-use. See rights and permissions. Published by BMJ.
RCT Entities: Population
Interventions
Outcomes
BACKGROUND: Erector spinae plane block (ESPB) is a novel regional anesthesia technique that is gaining popularity for postoperative pain management. This randomized controlled trial evaluated the effect of ESPB on quality of recovery (QoR) in patients undergoing modified radical mastectomy. METHODS: Eighty-two female patients undergoing modified radical mastectomy were included. Patients were randomly assigned to receive preoperative ultrasound-guided ESPB with either 0.5% ropivacaine or saline. The primary outcome was QoR, assessed 24 hours postoperatively using the 15-item QoR questionnaire (QoR-15). Secondary outcomes included postoperative pain scores, postoperative cumulative opioid consumption, postanesthesia care unit (PACU ) discharge time, postoperative nausea or vomiting and dizziness . RESULTS: Global QoR-15 scores 24 hours postoperatively were significantly higher (indicating better quality) in the ESPB group (median 120, IQR 118-124) compared with the control group (median 110, IQR 108.3-112.8), with a median difference of 10 (95% CI 9 to 12, p<0.001). Compared with the control group, ESPB with ropivacaine reduced pain scores up to 8 hours after surgery, as well as reduced postoperative cumulative opioid consumption and PACU discharge time. CONCLUSIONS: A single preoperative injection of ESPB with ropivacaine may improve QoR postoperatively and acute postoperative analgesia in patients undergoing a modified radical mastectomy. TRIAL REGISTRATION NUMBER: ChiCTR-1800019599. © American Society of Regional Anesthesia & Pain Medicine 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Entities: Chemical
Disease
Species
Keywords:
acute pain; interventional pain management; postoperative pain; truncal blocks
Year: 2019
PMID: 31678959 DOI: 10.1136/rapm-2019-100983
Source DB: PubMed Journal: Reg Anesth Pain Med ISSN: 1098-7339 Impact factor: 6.288